Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
8.35
-0.19 (-2.22%)
At close: Aug 1, 2025, 4:00 PM
8.35
0.00 (0.00%)
After-hours: Aug 1, 2025, 4:10 PM EDT
ANSYS Employees
Phathom Pharmaceuticals had 427 employees as of December 31, 2024. The number of employees decreased by 25 or -5.53% compared to the previous year.
Employees
427
Change (1Y)
-25
Growth (1Y)
-5.53%
Revenue / Employee
$191,707
Profits / Employee
-$809,813
Market Cap
581.56M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 427 | -25 | -5.53% |
Dec 31, 2023 | 452 | 340 | 303.57% |
Dec 31, 2022 | 112 | 35 | 45.45% |
Dec 31, 2021 | 77 | 22 | 40.00% |
Dec 31, 2020 | 55 | 30 | 120.00% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PHAT News
- 4 days ago - Phathom Pharmaceuticals to Report Second Quarter 2025 Financial Results and Provide Business Update on Thursday, August 7, 2025 - GlobeNewsWire
- 5 weeks ago - Phathom Pharmaceuticals: Potential Blockbuster Gastric Acid-Reducing Drug With New Mechanism - Seeking Alpha
- 5 weeks ago - Phathom Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Phathom Pharmaceuticals Appoints Anne Marie Cook as Chief Legal Officer and Corporate Secretary - GlobeNewsWire
- 6 weeks ago - Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032 - GlobeNewsWire
- 7 weeks ago - Tiny Phathom Pharmaceuticals Just An Got FDA Blessing And Big-Time Upside: Buy - Seeking Alpha
- 2 months ago - Phathom Pharmaceuticals Announces Positive FDA Decision to Recognize 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets through May 3, 2032 - GlobeNewsWire
- 2 months ago - Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire